Prosecution Insights
Last updated: October 02, 2026

The University of British Columbia

Technology area: Biotechnology & Pharmaceuticals

28 pending office actions • 21 art units • 28 examiners • 0 of 28 (0%) have an AI response strategy ready • 33 patents granted in the last 365 days

Analysis

The University of British Columbia has 28 pending office actions in the Biotechnology & Pharmaceuticals technology area. Each of these 28 actions is assigned to a different distinct examiner, resulting in no examiner overlap within the current pending set. The portfolio spans 22 distinct art units, showing a high degree of technical variety for a relatively small number of actions.

VARGAS MONTALVO, DIXOMARA is the busiest examiner for the university, currently overseeing 1 pending office action. Because each of the 28 pending office actions is handled by a different examiner, the university must navigate 28 unique individual perspectives. The involvement of 22 distinct art units for 28 actions indicates that the university's biotechnological research is spread across many different technical divisions at the USPTO. This requires a prosecution approach that is tailored to each specific case, as there is no opportunity to leverage a relationship with a single examiner across multiple pending matters.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

28
Total Pending OAs
18
Non-Final OAs
8
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

9
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (9)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

16
Hard (57%)
10
Medium (36%)
1
Easy (4%)
1
Unknown (4%)

Rejection Statute Mix

BucketCases
§101 + other3 (11%)
§103 only5 (18%)
§102 only3 (11%)
Double-patenting only1 (4%)
Double-patenting + other2 (7%)
Multi-statute (no §101)13 (46%)
No statute on record1 (4%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

18
Life Sciences
64% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
4
Semiconductors
14% of docket
2
Mechanical / Eng
7% of docket
4
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

280 h
Manual time on pending OAs
56 h
Time saved (low, 20%)
98 h
Time saved (mid, 35%)
2.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VARGAS MONTALVO, DIXOMARA 1 92.6% +8.4%
YOUNG, MICAH PAUL 1 55.1% +30.0%
HEINCER, LIAM J 1 55.8% +26.0%
KIRKLAND III, FREDDIE 1 84.4% +10.4%
SHTERENGARTS, SAMANTHA L 1 79.5% +8.0%
HOQUE, MOHAMMAD M 1 85.2% +9.5%
FADUL, PHILIPMARCUS T 1 81.6% +11.7%
TRAN, TRAN M. 1 74.8% +23.4%
TRAN, SUSAN T 1 62.8% +35.1%
HE, AMY 1 81.3% +4.3%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18539523 CAPACITANCE SENSOR AND CAPACITANCE SENSOR MANUFACTURING METHOD HE, AMY 5d overdue
18890807 FORCE SENSOR KIRKLAND III, FREDDIE —

Hard Cases (16)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18317071 PROBIOTIC COMPOSITIONS AND USES THEREOF DEVI, SARVAMANGALA 38d overdue
17919455 ELECTROLYTIC CONVERSION OF CARBON-CONTAINING IONS USING POROUS METAL ELECTRODES PARENT, ALEXANDER RENE 35d overdue
17919459 COMPOSITIONS AND METHODS FOR INHIBITING TDP-43 AND FUS AGGREGATION POLIAKOVA-GEORGAN, EKATERINA 15d overdue
18458088 APPARATUS AND METHODS FOR COMBINATORIAL MATERIAL SCREENING AND DISCOVERY MILLER, JR, JOSEPH ALBERT 9d overdue
17561408 MOLECULAR SUBTYPING, PROGNOSIS, AND TREATMENT OF BLADDER CANCER VANN-OJUEKAIYE, KENDRA RAYCHELL 4d overdue
19408302 METHODS AND APPARATUS FOR NEAR INFRARED SPECTROSCOPY VARGAS MONTALVO, DIXOMARA —
18839351 METHODS OF FABRICATING MICRO ELECTRO-MECHANICAL SYSTEMS STRUCTURES HOQUE, MOHAMMAD M —
18736584 ELECTRIC CIRCUIT BODY AND ELECTRONIC DEVICE FADUL, PHILIPMARCUS T —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
19030494 LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS YOUNG, MICAH PAUL —
18947297 AEROGELS ASSEMBLED FROM MICROFIBERS, METHODS FOR THEIR PREPARATION AND USES THEREOF HEINCER, LIAM J —
18890807 FORCE SENSOR KIRKLAND III, FREDDIE —
18736584 ELECTRIC CIRCUIT BODY AND ELECTRONIC DEVICE FADUL, PHILIPMARCUS T —
18735207 APPARATUS FOR GAS SAMPLE COLLECTION TRAN, TRAN M. —
18679820 VISCOSUPPLEMENT COMPOSITIONS TRAN, SUSAN T —

Top Art Units

Art UnitApps
2855 2
1619 2
1682 2
3798 1
1767 1
1615 1
2858 1
1691 1
1632 1
3773 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19408302 METHODS AND APPARATUS FOR NEAR INFRARED SPECTROSCOPY VARGAS MONTALVO, DIXOMARA 3798 §102§103§112 Non-Final OA — Pending Dec 03, 2025
19030494 LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS YOUNG, MICAH PAUL — DP Non-Final OA — Pending Jan 17, 2025
18947297 AEROGELS ASSEMBLED FROM MICROFIBERS, METHODS FOR THEIR PREPARATION AND USES THEREOF HEINCER, LIAM J 1767 §103 Final Rejection — Pending Nov 14, 2024
18890807 FORCE SENSOR KIRKLAND III, FREDDIE — §102 Non-Final OA — Pending Sep 20, 2024
18846525 ALOTAKETAL COMPOUNDS AND DERIVATIVES THEREOF FOR USE AS ANTIVIRAL AGENTS SHTERENGARTS, SAMANTHA L — §102 Non-Final OA — Pending Sep 12, 2024
18839351 METHODS OF FABRICATING MICRO ELECTRO-MECHANICAL SYSTEMS STRUCTURES HOQUE, MOHAMMAD M — §102§103 Non-Final OA — Pending Aug 16, 2024
18736584 ELECTRIC CIRCUIT BODY AND ELECTRONIC DEVICE FADUL, PHILIPMARCUS T 2855 §102§103 Non-Final OA — Pending Jun 07, 2024
18735207 APPARATUS FOR GAS SAMPLE COLLECTION TRAN, TRAN M. 2855 §102§103§112 Non-Final OA — Pending Jun 06, 2024
18679820 VISCOSUPPLEMENT COMPOSITIONS TRAN, SUSAN T 1615 §102§103 Non-Final OA — Pending May 31, 2024
18539523 CAPACITANCE SENSOR AND CAPACITANCE SENSOR MANUFACTURING METHOD HE, AMY 2858 §103 Final Rejection 5d overdue Pending Dec 14, 2023
18564588 MRNA DELIVERY USING LIPID NANOPARTICLES GREENE, IVAN A 1619 §103 Non-Final OA 46d overdue Pending Nov 30, 2023
18565049 Polymeric Antifouling Coating with Antimicrobial Peptides JOHNSON, CHRISTOPHER LINDSAY 1691 §102§103 Non-Final OA — Pending Nov 28, 2023
18563344 DIAGNOSTIC FOR SEPSIS ENDOTYPES AND/OR SEVERITY DAUNER, JOSEPH G 1682 §101§102§103§112 Non-Final OA — Pending Nov 21, 2023
18561873 A METHOD FOR PRODUCING BLOOD PROGENITOR AND PROGENITOR T CELLS, RESULTING CELLS AND METHODS AND USES THEREOF CORDAS, EMILY ANN 1632 §102§103§112 Non-Final OA — Pending Nov 17, 2023
18493737 BONE-FIXATION DEVICE AND SYSTEM MATTHEWS, TESSA M 3773 §103 Non-Final OA 26d Pending Oct 24, 2023
18285019 USE OF PSYCHEDELICS TO TREAT DEMENTIA BORALSKY, LUKE ALAN 1624 §103§112DP Non-Final OA — Pending Sep 29, 2023
18458088 APPARATUS AND METHODS FOR COMBINATORIAL MATERIAL SCREENING AND DISCOVERY MILLER, JR, JOSEPH ALBERT 1712 §102§103 Final Rejection 9d overdue Pending Aug 29, 2023
18266787 CYTOCHROME P450 MONOOXYGENASES AND USES THEREOF HUTSON, RICHARD G 1652 §101§102 Final Rejection — Pending Jun 12, 2023
18317071 PROBIOTIC COMPOSITIONS AND USES THEREOF DEVI, SARVAMANGALA 1645 §102§103§112 Non-Final OA 38d overdue Pending May 13, 2023
18035578 A Method of Treating Depression by Immune Modulation PIHONAK, SARAH 1627 §102§103§112DP Non-Final OA — Pending May 05, 2023
18015159 SILVER ENHANCED CANNABINOID ANTIBIOTICS ALAWADI, SARAH 1619 §103§112 Non-Final OA — Pending Jan 09, 2023
17919455 ELECTROLYTIC CONVERSION OF CARBON-CONTAINING IONS USING POROUS METAL ELECTRODES PARENT, ALEXANDER RENE 1795 §103§112 Final Rejection 35d overdue Pending Nov 01, 2022
17920448 HYDROGEN PERMEABLE MEMBRANES, REACTORS AND RELATED METHODS SYLVESTER, KEVIN 1794 §103§112 Non-Final OA — Pending Oct 21, 2022
17919459 COMPOSITIONS AND METHODS FOR INHIBITING TDP-43 AND FUS AGGREGATION POLIAKOVA-GEORGAN, EKATERINA 1637 §102§103§112 Non-Final OA 15d overdue Pending Oct 17, 2022
17843561 MICROMOTOR-INTEGRATED ENDOSCOPIC SIDE-VIEWING PROBE STANFORD, CHRISTOPHER J 2872 §103 Final Rejection 147d overdue Pending Jun 17, 2022
17561408 MOLECULAR SUBTYPING, PROGNOSIS, AND TREATMENT OF BLADDER CANCER VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §101§103DP Non-Final OA 4d overdue Pending Dec 23, 2021
17321645 HIGHLY PARALLEL ASSAYS FOR SIMULTANEOUS IDENTIFICATION OF ANTIBODY SEQUENCES AND BINDING PARTNERS WILSON, MICHAEL C 1638 Other Final Rejection 2d overdue Pending May 17, 2021
17282319 Transcription Factor BRN2 Inhibitory Compounds as Therapeutics and Methods for Their Use VAJDA, KRISTIN ANN 1622 §102 Final Rejection — Pending Apr 01, 2021

Managing The University of British Columbia's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month